| In vivo imaging of microglial activation with [11C](R)-PK11195 PET in idiopathic Parkinson's disease A Gerhard, N Pavese, G Hotton, F Turkheimer, M Es, A Hammers, ... Neurobiology of disease 21 (2), 404-412, 2006 | 1288 | 2006 |
| Microglia, amyloid, and cognition in Alzheimer's disease: An [11C](R) PK11195-PET and [11C] PIB-PET study P Edison, HA Archer, A Gerhard, R Hinz, N Pavese, FE Turkheimer, ... Neurobiology of disease 32 (3), 412-419, 2008 | 620 | 2008 |
| Amyloid, hypometabolism, and cognition in Alzheimer disease: an [11C] PIB and [18F] FDG PET study P Edison, HA Archer, R Hinz, A Hammers, N Pavese, YF Tai, G Hotton, ... Neurology 68 (7), 501-508, 2007 | 618 | 2007 |
| Brain-first versus body-first Parkinson’s disease: a multimodal imaging case-control study J Horsager, KB Andersen, K Knudsen, C Skjærbæk, TD Fedorova, ... Brain 143 (10), 3077-3088, 2020 | 599 | 2020 |
| Microglial activation correlates with severity in Huntington disease: a clinical and PET study N Pavese, A Gerhard, YF Tai, AK Ho, F Turkheimer, RA Barker, DJ Brooks, ... Neurology 66 (11), 1638-1643, 2006 | 544 | 2006 |
| Dyskinesias following neural transplantation in Parkinson's disease P Hagell, P Piccini, A Björklund, P Brundin, S Rehncrona, H Widner, ... Nature neuroscience 5 (7), 627-628, 2002 | 536 | 2002 |
| Compulsive drug use linked to sensitized ventral striatal dopamine transmission AH Evans, N Pavese, AD Lawrence, YF Tai, S Appel, M Doder, DJ Brooks, ... Annals of Neurology: Official Journal of the American Neurological …, 2006 | 522 | 2006 |
| Microglial activation in presymptomatic Huntington's disease gene carriers YF Tai, N Pavese, A Gerhard, SJ Tabrizi, RA Barker, DJ Brooks, P Piccini Brain 130 (7), 1759-1766, 2007 | 513 | 2007 |
| The Parkinson's progression markers initiative (PPMI)–establishing a PD biomarker cohort K Marek, S Chowdhury, A Siderowf, S Lasch, CS Coffey, ... Annals of clinical and translational neurology 5 (12), 1460-1477, 2018 | 453 | 2018 |
| Age at onset and Parkinson disease phenotype G Pagano, N Ferrara, DJ Brooks, N Pavese Neurology 86 (15), 1400-1407, 2016 | 401 | 2016 |
| Mutations in the gene LRRK2 encoding dardarin (PARK8) cause familial Parkinson's disease: clinical, pathological, olfactory and functional imaging and genetic data NL Khan, S Jain, JM Lynch, N Pavese, P Abou-Sleiman, JL Holton, ... Brain 128 (12), 2786-2796, 2005 | 382 | 2005 |
| Fatigue in Parkinson’s disease is linked to striatal and limbic serotonergic dysfunction N Pavese, V Metta, SK Bose, KR Chaudhuri, DJ Brooks Brain 133 (11), 3434-3443, 2010 | 372 | 2010 |
| Reference and target region modeling of [11C]-(R)-PK11195 brain studies FE Turkheimer, P Edison, N Pavese, F Roncaroli, AN Anderson, ... Journal of Nuclear Medicine 48 (1), 158-167, 2007 | 345 | 2007 |
| Cognitive deficits and striato-frontal dopamine release in Parkinson's disease N Sawamoto, P Piccini, G Hotton, N Pavese, K Thielemans, DJ Brooks Brain 131 (5), 1294-1302, 2008 | 332 | 2008 |
| Factors affecting the clinical outcome after neural transplantation in Parkinson's disease P Piccini, N Pavese, P Hagell, J Reimer, A Björklund, WH Oertel, ... Brain 128 (12), 2977-2986, 2005 | 312 | 2005 |
| In-vivo staging of pathology in REM sleep behaviour disorder: a multimodality imaging case-control study K Knudsen, TD Fedorova, AK Hansen, M Sommerauer, M Otto, ... The Lancet Neurology 17 (7), 618-628, 2018 | 294 | 2018 |
| Progressive striatal and cortical dopamine receptor dysfunction in Huntington’s disease: a PET study N Pavese, TC Andrews, DJ Brooks, AK Ho, AE Rosser, RA Barker, ... Brain 126 (5), 1127-1135, 2003 | 253 | 2003 |
| Trial of prasinezumab in early-stage Parkinson’s disease G Pagano, KI Taylor, J Anzures-Cabrera, M Marchesi, T Simuni, K Marek, ... New England Journal of Medicine 387 (5), 421-432, 2022 | 252 | 2022 |
| Microglial activation in regions related to cognitive function predicts disease onset in Huntington's disease: a multimodal imaging study M Politis, N Pavese, YF Tai, L Kiferle, SL Mason, DJ Brooks, SJ Tabrizi, ... Human brain mapping 32 (2), 258-270, 2011 | 248 | 2011 |
| Glutamate NMDA receptor dysregulation in Parkinson’s disease with dyskinesias I Ahmed, SK Bose, N Pavese, A Ramlackhansingh, F Turkheimer, ... Brain 134 (4), 979-986, 2011 | 246 | 2011 |
